Provided by Tiger Trade Technology Pte. Ltd.

MRBL Enhanced Equity ETF

51.70
+0.15740.31%
Volume:297
Turnover:15.38K
Market Cap:11.89M
PE:- -
High:51.70
Open:51.62
Low:51.62
Close:51.55
52wk High:51.98
52wk Low:41.64
Shares:230.00K
Float Shares:230.00K
Volume Ratio:0.10
T/O Rate:0.13%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Company Profile

Company Name:
MRBL Enhanced Equity ETF
Exchange:
CBOE
Establishment Date:
2025
Employees:
- -
Office Location:
3803 West Chester Pike,Suite 150,Newtown Square,Pennsylvania,United States
Zip Code:
19073
Fax:
216 245 3686
Introduction:
Edge Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and commercializes hospital-based therapies for acute life-threatening neurological conditions. Its lead product includes EG-1962, a polymer-based microparticle used for the treatment of aneurysmal subarachnoid hemorrhage. The company also develops EG-1964 for the management of chronic subdural hematoma as a prophylactic treatment to prevent recurrent bleeding. The company was founded in 2009 and is headquartered in Berkeley Heights, New Jersey.